Christopher D. Roberts - Net Worth and Insider Trading
Christopher D. Roberts Net Worth
The estimated net worth of Christopher D. Roberts is at least $14,656 dollars as of 2024-09-20. Christopher D. Roberts is the Chief Scientific Officer of Black Diamond Therapeutics Inc and owns about 3,200 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $14,656. Details can be seen in Christopher D. Roberts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher D. Roberts has not made any transactions after 2021-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher D. Roberts
Christopher D. Roberts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher D. Roberts owns 1 companies in total, including Black Diamond Therapeutics Inc (BDTX) .
Click here to see the complete history of Christopher D. Roberts’s form 4 insider trades.
Insider Ownership Summary of Christopher D. Roberts
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-03-03 | Chief Scientific Officer |
Christopher D. Roberts Latest Holdings Summary
Christopher D. Roberts currently owns a total of 1 stock. Christopher D. Roberts owns 3,200 shares of Black Diamond Therapeutics Inc (BDTX) as of March 3, 2021, with a value of $14,656.
Latest Holdings of Christopher D. Roberts
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-03-03 | 3,200 | 4.58 | 14,656 |
Holding Weightings of Christopher D. Roberts
Christopher D. Roberts Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher D. Roberts has made a total of 8 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 2,500 shares on March 3, 2021, which brought Christopher D. Roberts around $65,250.
Insider Trading History of Christopher D. Roberts
- 1
Christopher D. Roberts Trading Performance
Christopher D. Roberts Ownership Network
Christopher D. Roberts Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Christopher D. Roberts is the Chief Scientific Officer of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Christopher D. Roberts made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Christopher D. Roberts Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher D. Roberts. You might contact Christopher D. Roberts via mailing address: C/o Black Diamond Therapeutics, Inc., 139 Main Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
